Novo’s Catalent Acquisition Surprises Some Analysts, Raises Questions about Existing Contracts

While analysts are bullish on Novo Holdings’ $16.5 billion acquisition of Catalent, they say it raises questions for companies that have contracted the CDMO for manufacturing.